Know Your AATmosphere
Support System

Staying as healthy as possible

For people challenged with AAT deficiency, preventing or slowing lung damage is critical. Avoiding exposure to lung irritants in your environment, such as some household chemicals, allergens, and secondhand smoke is a must. Ask your physician how proper diet and exercise can also help strengthen your ability to live a longer, more fulfilling life. A commitment to eating well and staying active can benefit the body as well as the mind.

Avoiding smoke and other lung irritants

Did you know there are more than 4,000 chemicals in cigarette smoke, some of which may make it harder to quit?1,2 And that even secondhand smoke can damage your heart and lungs over time, and minimize your ability to fight infections?

If someone in your family smokes, there are many effective ways to quit. Convenient help, such as the American Lung Association's Freedom From Smoking® Program, is available online. Click on www.lungusa.org.

-- back to top --

Staying active with Alpha-1

For people with COPD, findings from a 2007 study published in Heart and Lung suggest that physical benefits come with strict adherence to an exercise routine. Additionally, mental health benefits can arise from regular exercise, even if the activity isn't constant.3

Pulmonary rehabilitation, a comprehensive and customized approach toward fitness, can also improve your quality of life. It generally includes:

Be sure to choose an AACVPR-certified (American Association of Cardiovascular and Pulmonary Rehabilitation) program, to ensure credibility and effectiveness. Your choice of program will no doubt require your physician’s approval, and possible pre-testing.

Relaxation techniques, such as yoga, may also be helpful. Talk to your physician about the exercise plan that's right for you.

-- back to top --

Maintaining your overall health, morning to night

Here are some simple measures to maintain or improve pulmonary health at home and away:

Click below for more information:

www.aacvpr.org
www.alpha1health.com
www.breathingbetterlivingwell.com
www.ehealthmd.com/library/Emphysema/EMP faq.html
www.lungusa.org
www.smokefree.gov

-- back to top --

These links are provided for your convenience. However, they lead to external websites not created, managed, or maintained by Baxter. Baxter is not responsible for, and does not necessarily endorse, the opinions or products represented on these external pages.

ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.

Please see the ARALAST Important Safety Information and Full Prescribing Information.

  1. National Cancer Institute, U.S. National Institutes of Health. Cigarette Smoking and Cancer: Questions and Answers. Available at: http://www.cancer.gov/cancertopics/factsheet/tobacco/cancer. Accessed October 4, 2007.
  2. Rabinoff MD, Caskey N, Rissling A, Park C. Pharmacological and chemical effects of cigarette additives. Am J Public Health [Epub ahead of print]. 2007. Available at: http://www.ajph.org/cgi/reprint/AJPH.2005.078014v2. Accessed September 14, 2007.
  3. Donesky-Cuenco D, Janson S, Neuhaus J, et al. Adherence to a home-walking prescription in patients with chronic obstructive pulmonary disease. Heart Lung. 2007;36:348-363.